Sponsor content
320 result(s) found, displaying 31 to 40
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALIPERIDONE-TEVA paliperidone (as palmitate) 150 mg/1.5 mL modified release suspension for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALIPERIDONE-TEVA paliperidone (as palmitate) 100 mg/1.0 mL modified release suspension for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALIPERIDONE-TEVA paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALIPERIDONE-TEVA paliperidone (as palmitate) 75 mg/0.75 mL modified release suspension for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALIPERIDONE-TEVA paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: azelastine hydrochloride, fluticasone propionate.